High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1615-1619

  Harada, Koji ^a   Kawashima, Yuichiro ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Immunohistochemistry; Jab1; Prognosis; Radiation; UFT

Indexed keywords

ANTINEOPLASTIC AGENT; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; TEGAFUR; TUMOR MARKER; UNCLASSIFIED DRUG; URACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; ORAL BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PEPTIDE HYDROLASES; PROGNOSIS; TEGAFUR; URACIL;

EID: 33645824561     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kip1 protein: prognostic implications in primary breast cancer. Nature Med 3: 227-230, 1997.
2. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG et al: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385, 1997.
3. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K et al: P27 expression and gastric carcinoma. Nature Med 3: 593, 1997.
4. Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma. Anticancer Res 22: 2985-2989, 2002.
5. Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154: 313-323, 1999.
6. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T et al: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55: 2266-2269, 1995.
7. Kip1 is instigated by Jab1. Nature 398: 160-165, 1999.
8. Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 277: 2302-2310, 2002.
9. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y et al: Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res 7: 4130-4135, 2003.
10. Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C and Claret FX: Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res 63: 2977-2981, 2003.
11. Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y et al: Jun activation domain binding protein 1 expression is associated with low p27(Kip1) levels in node-negative breast cancer. Clin Cancer Res 9: 5652-5659, 2003.
12. Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncol Rep 11: 277-284, 2004.
13. Shintani S, Li C, Mihara M, Hino S, Nakashiro K and Hamakawa H: Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology 65: 355-362, 2003.
14. Ito Y, Yoshida H, Matsuzuka F, Matsuura N, Nakamura Y, Nakamine H et al: Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Anticancer Res 23: 4121-4125, 2003.
15. Ito Y, Miyoshi E, Uda E, Yoshida H, Uruno T, Takamura Y et al: 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Cancer Lett 196: 87-91, 2003.
16. Kip1 protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 87: 2635-2643, 2002.
17. Rassidakis GZ, Claret FX, Lai R, Zhang Q, Sarris AH, McDonnell TJ et al: Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res 9: 1121-1128, 2002.
18. Johnson NW: Epidemiology of oral cancer in risk markers of oral disease. In: Johnson NW (ed.). Oral Cancer, vol.2. Cambridge, UK: Cambridge University Press, pp. 3-26, 1991.
19. Thomas GJ, Jones J and Speight PM: Integrins and oral cancer. Oral Oncol 33: 381-388, 1997.
20. Ramos DM, Chen BL, Boylen K, Stern M, Kvamer RH, Sheppard D et al: Stromal fibroblast influence oral squamous-cell carcinoma cell interactions with tenascin-C. Int J Cancer 72: 369-372, 1997.
21. Silverman S Jr: Oral Cancer, 4th.ed, BC Becker, Ontario, 1998.
22. Sobin LH and Wittekind Ch: TNM Classification of Malignant Tumours. International Union Against Cancer (UICC), Ed. 5. New York: Wiley-Liss, pp. 20-37, 1997.
23. Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154: 313-323, 1999.
24. Harada K, Supriatno, Kawaguchi S, Kawashima Y, Itashiki Y, Yoshida H et al: High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation. Anticancer Res 25: 2471-2475, 2005.
25. Carrano AC, Eytan E, Hershko A and Pagano M: Skp2 is required for ubiquitin-mediated degradation of the Cdk inhibitor p27. Nat Cell Biol 1: 193-197, 1999.
26. Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1: 207-214, 1999.
27. Hara T, Kamura T, Kotoshiba S, Takahashi H, Fujiwara K, Onoyama I et al: Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle. Mol Cell Biol 25: 9292-9303, 2005.
28. Kotoshiba S, Kamura T, Hara T, Ishida N and Nakayama KI: Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J Biol Chem 280: 17694-17700, 2005.
29. Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, Hatakeyama S et al: Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol 6: 1229-1235, 2004.